Royalty Pharma plc (RPRX) Reports Q2 Revenue of $555 Million

Royalty Pharma plc (NASDAQ: RPRX) reported Q2 revenue of $555 million, versus $511 million reported last year.

• Increased 2021 guidance: Adjusted Cash Receipts(1) expected to be $2,080 to $2,120 million

For earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Unity Bancorp CEO to retire in 2027, president to take over
• Espey Manufacturing (ESP) Tops Q4 EPS by 24c